Brief: Addex ADX71149 Epilepsy Phase 2 Study Completes Recruitment Of Patients
14/11/2023 06:01
Nov 14 (Reuters) - Addex Therapeutics Ltd ADXN.S :
* ADDEX ADX71149 EPILEPSY PHASE 2 STUDY COMPLETES
RECRUITMENT OF
PATIENTS
Source text for Eikon: ID:nGNXRSMMg
Further company coverage: ADXN.S
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Addex Therapeutics
See all newsBrief: Addex Spin-Out Neurosterix Completes Phase 1 Clinical Studies Of NTX-253 For Schizophrenia
NASDAQ RESUMED AT 11:29 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 11:24 AM
Switzerland's Addex Therapeutics Q2 net loss narrows on decline in R&D expenses
Brief: Addex Therapeutics Q2 Operating Income CHF -645 Thousand